Custom service
Cyclic Peptide Screening
Screen cyclic peptide collections against your assay
The service is built around collection formatting and plating. Depending on the molecule we may move to primary and confirmatory screening or hit triage and resupply to improve stability, loading or yield, and every batch is released with screening report with confirmed hits.
Because Cyclic Peptide Screening projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Screening in-house cyclic collections
Follow-up on external screening hits
Screens requiring containment levels above BSL-2
Cycles whose ring size is known to be geometrically uncloseable
Cyclic products are released against connectivity, not mass alone. MS/MS fragmentation confirms the ring closure, and where multiple topologies are possible the target isomer is isolated and its ratio reported. Protease-stability data are available as an add-on.
Service Highlights
- Collection formatting and plating as the default route, with primary and confirmatory screening held as a proven fallback
- Hit triage and resupply worked into the design where the application requires it
- Cyclization strategy (head-to-tail, disulfide, lactam, thioether) chosen from a feasibility screen, not fixed by habit
- Analytical confirmation of every intermediate before the final release
- Cyclic/linear and topological isomers separated and reported, with the target isomer identified by MS/MS
- Screening report with confirmed hits delivered with a complete conjugation or synthesis certificate
How the work runs
Precursor design
Linear precursor, cyclization sites and protecting strategy are designed around the Cyclic Peptide Screening ring size.
Linear assembly
The precursor chain is assembled with Fmoc chemistry and collection formatting and plating where relevant.
Cyclization
Ring closure is executed by primary and confirmatory screening under screened dilution and activation conditions.
Isomer separation
RP-HPLC resolves cyclic/linear and topological isomers; the target isomer is collected.
Characterization
Connectivity, purity and identity are confirmed by MS/MS and HPLC against the specification.
Release
Screening report with confirmed hits is documented and released after QC sign-off.
Specifications & timeline
- Turnaround
- 4–8 weeks
- Typical scale
- 1 – 200 mg cyclic peptide
- Chemistry options
- collection formatting and plating; primary and confirmatory screening; hit triage and resupply
- Deliverable
- Screening report with confirmed hits
- QC package
- HPLC purity, MS/MS connectivity proof, isomer ratio, DMSO solubility
- Shipping
- Ambient with desiccant; blue ice for sensitive motifs
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.